Advertising Policy

Currently all journals published by the Multidisciplinary Publishing Institute (SMC-Private) Limited are not publishing any advertisement. In case of any future decision to publish a sponsored/ paid advertisement, it shall be subject to the below advertising policy:

  1. Open Access Organization and Management Review reserves the right to decline any type of advertising that is harmful to the Open Access Organization and Management Review or if it is unsuitable to the content of the Open Access Organization and Management Review network. Open Access Organization and Management Review will not accept advertising for products or services known to be detrimental to health (e.g. tobacco and alcohol products).
  2. All advertisements and commercially sponsored publications are independent from editorial decisions. The journal does not endorse any product or service marked as an advertisement or promoted by a sponsor in Open Access Organization and Management Review publications. The management of the will ensure that the editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising sponsors.
  3. Advertisements may not be misleading / deceptive, it must be verifiable, clearly identify the advertiser. Exaggerated advertisement shall not be allowed. Advertisements will not be accepted only if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  4. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher request its removal. Open Access Organization and Management Review will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised.
  5. All advertisements for drug-specific campaigns must comply with the relevant legislation that regulates advertising. In the case of drug advertisements, the full generic name of each active ingredient should appear. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  6. Advertisements and editorial content must be clearly distinguishable. Open Access Organization and Management Review will not publish “advertorial” content. The sponsored contents must be clearly indicated. If a content did not undergo peer review or underwent a peer review-process different from the rest of the journal, then it must be unambiguously expressed.
  7. The journal’s Editorial decisions shall not be influenced by current or potential advertisers and shall not be influenced by marketing decisions. Advertisers and sponsors shall have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.
  8. Information about complaints concerning advertisements will be included in the Advertisements page. If any advertisement is requested outside of Open Access Organization and Management Review standard advertising positions, then a request should be made to editorial who will respond with a full and final decision within seven working days.

Advertising complaints policy

Please send any complaints about advertising to: info@mdpip.com